These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 8109004

  • 1. Occult rejection in renal allografts: preconversion biopsies and postconversion rejection in recipients converted from cyclosporine to azathioprine alone at 6 to 12 months after transplantation.
    Rodriguez C, Naffah M, Pinto A, Mendez A, Arminio A, Stempel C, Milanes CL, Weisinger J.
    Transplant Proc; 1994 Feb; 26(1):333-4. PubMed ID: 8109004
    [No Abstract] [Full Text] [Related]

  • 2. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V, Jirasiritham S, Chiewsilp P.
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract] [Full Text] [Related]

  • 3. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 4. Renal allograft biopsy and conversion of cyclosporine to azathioprine.
    Shen SY, Weir MR, Coughlin TR.
    Transplantation; 1989 Feb; 47(2):223-9. PubMed ID: 2645702
    [Abstract] [Full Text] [Related]

  • 5. Conversion from cyclosporine to azathioprine in renal graft recipients.
    MacDonald AS, Belitsky P, Gupta R, Bitter-Suermann H, Campbell R, Cohen A, Lannon SG.
    Transplant Proc; 1985 Aug; 17(4):1940-2. PubMed ID: 3895634
    [Abstract] [Full Text] [Related]

  • 6. Do steroids matter in one-haplotype pediatric renal allograft recipients on cyclosporine/azathioprine?
    David-Neto E, Ianhez LE, Nahas WC, Krasilcic S, Sabbaga E, Arap S.
    Transplant Proc; 1994 Feb; 26(1):95-6. PubMed ID: 8109040
    [No Abstract] [Full Text] [Related]

  • 7. Renal graft survival in children with early acute rejection.
    Muñoz R, Romero B, Medeiros M, Zaragoza L.
    Pediatr Transplant; 1998 Nov; 2(4):294-8. PubMed ID: 10084732
    [Abstract] [Full Text] [Related]

  • 8. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients.
    Pourfarziani V, Taheri S.
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):991-4. PubMed ID: 19861858
    [Abstract] [Full Text] [Related]

  • 10. Impact of cyclosporin on the incidence and prevalence of chronic rejection in renal transplants.
    Beckingham IJ, O'Rourke JS, Stubington SR, Hinwood M, Bishop MC, Rigg KM.
    Ann R Coll Surg Engl; 1997 Mar; 79(2):138-42. PubMed ID: 9135244
    [Abstract] [Full Text] [Related]

  • 11. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 12. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection.
    Brook NR, White SA, Waller JR, Bicknell GR, Nicholson ML.
    Br J Surg; 2003 Aug; 90(8):1009-14. PubMed ID: 12905557
    [Abstract] [Full Text] [Related]

  • 13. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Aug; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 14. Acute irreversible rejection after withdrawal of azathioprine in renal allograft recipients.
    Shiramizu T, Nakamura K, Hida M, Shinbo T, Nakayama M, Saitoh H, Satoh T, Hata J, Tsuji K.
    Tokai J Exp Clin Med; 1981 Jul; 6(3):315-9. PubMed ID: 7029783
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

  • 16. The importance of early cyclosporine levels in pediatric kidney transplantation.
    Matas AJ, Gillingham KJ, Chavers BM, Nevins T, Kashtan C, Mauer SM, Payne WD, Gruessner R, Najarian JS.
    Clin Transplant; 1996 Dec; 10(6 Pt 1):482-6. PubMed ID: 8996767
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 19. Role of postdose cyclosporine monitoring in living renal transplant recipients.
    Thomas R, Minz M, Singh B, Heer M, Kashyap R.
    Transplant Proc; 2004 Sep 15; 36(7):2104. PubMed ID: 15518761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.